Parkinson's Disease Associated With Major Melanoma Risk10/23/06 [Medscape Medical News] Patients with Parkinson's disease have a more than 2-fold increased risk of developing malignant melanoma compared with the general population, a new study has found.
Switching Triptans Can Improve Outcomes for Migraine Sufferers10/19/06 [Medscape Medical News] A new study suggests migraine sufferers who are triptan experienced frequently report better effectiveness and tolerability when they switch to another triptan. The key may lie in finding the right triptan for the right patient.
Lacosamide Promising in Relief of Painful Diabetic Neuropathy10/13/06 [Medscape Medical News] Results of a multicenter randomized trial of a still-investigational anticonvulsant drug, lacosamide, suggests the drug is both most efficacious and well tolerated at a dose of 400 mg/day.
SPARCL: Recurrent Strokes Less Severe on Atorvastatin Treatment10/12/06 [Medscape Medical News] A planned secondary analysis of the SPARCL trial shows that patients with a history of stroke or TIA were less likely to have a recurrent event or to have a less severe recurrent stroke if they were receiving treatment with atorvastatin.
IDEAL Study: First Alzheimer's Drug Patch, Safe, Effective, Convenient10/11/06 [Medscape Medical News] The first transdermal patch for the treatment of Alzheimer's disease is as effective as oral medication and offers patients a adverse-event profile that is comparable to placebo, a new study shows.
Fingolimod Effective to 24 Months in Relapsing MS10/10/06 [Medscape Medical News] Results of an extension study with oral fingolimod in patients with relapsing multiple sclerosis continue to show low disease activity on MRI as well as low rates of relapse, as was seen in the main study. Phase 3 trials of this drug are now under way.
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Neurological Association. These materials and the related activity are not sanctioned by the American Neurological Association or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
